Opus Point Partners Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $282K | Buy |
|
|||||
|
2019
Q2 | $254K | Buy |
|
|||||
|
2019
Q1 | $247K | Sell |
|
|||||
|
2018
Q4 | $213K | Sell |
|
|||||
|
2018
Q3 | $417K | Buy |
|
|||||
|
2018
Q2 | $301K | Sell |
|
|||||
|
2018
Q1 | $268K | Sell |
|
|||||
|
2017
Q4 | $326K | Sell |
|
|||||
|
2017
Q3 | $591K | Buy |
|
|||||
|
2017
Q2 | $238K | Sell |
|
|||||
|
2017
Q1 | $398K | Buy |
|
|||||
|
2016
Q4 | $238K | Buy |
|
|||||
|
2016
Q3 | $206K | Buy |
|